Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy
- PMID: 24824263
Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy
Abstract
Objective: To highlight current knowledge about M-type phospholipase A2 receptor (PLA2R) which is the first human autoantigen discovered in adult idiopathic membranous nephropathy.
Data sources: Relevant articles published in English from 2000 to present were selected from PubMed. Searches were made using the terms "idiopathic membranous nephropathy, M-type PLA2R and podocyte."
Study selection: Articles studying the role of M-type PLA2R in idiopathic membranous nephropathy were reviewed. Articles focusing on the discovery, detection and clinical observation of anti-PLA2R antibodies were selected.
Results: M-type PLA2R is a member of the mannose receptor family of proteins, locating on normal human glomeruli as a transmembrane receptor. The anti-PLA2R in serum samples from MN were primarily IgG4 subclass. Technologies applied to detect anti-PLA2R autoantibody are mainly WB, IIFT, ELISA and so on. Studies from domestic and overseas have identified a strongly relationship between circulating anti-PLA2R levels and disease activity.
Conclusion: Recent discoveries corresponding to PLA2R facilitate a better understanding on IMN pathogenesis and may provide a new tool to its diagnosis, differential diagnosis, risk evaluation, response monitoring and patient-specific treatment.
Similar articles
-
HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy.Medicine (Baltimore). 2016 Sep;95(37):e4809. doi: 10.1097/MD.0000000000004809. Medicine (Baltimore). 2016. PMID: 27631233 Free PMC article.
-
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases.J Nephrol. 2018 Apr;31(2):271-278. doi: 10.1007/s40620-017-0451-5. Epub 2017 Oct 28. J Nephrol. 2018. PMID: 29081027
-
Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.Nefrologia. 2014 May 21;34(3):353-9. doi: 10.3265/Nefrologia.pre2013.Dec.12291. Epub 2014 Feb 10. Nefrologia. 2014. PMID: 24798555 English, Spanish.
-
Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23. Autoimmun Rev. 2016. PMID: 26527329 Review.
-
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?].G Ital Nefrol. 2014 May-Jun;31(3):gin/31.3.13. G Ital Nefrol. 2014. PMID: 25030016 Review. Italian.
Cited by
-
Comparison of biomarkers between PLA2RAb+ and PLA2RAb- in patients with idiopathic membranous nephropathy.Int Urol Nephrol. 2015 May;47(5):831-5. doi: 10.1007/s11255-015-0956-6. Epub 2015 Mar 27. Int Urol Nephrol. 2015. PMID: 25812824
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources